By Kelly Knaub ( February 22, 2016, 8:51 PM EST) -- GlaxoSmithKline urged a Massachusetts' federal court on Monday to require all plaintiffs in multidistrict litigation over anti-nausea drug Zofran to identify whether they used the brand-name drug or its generic equivalent, saying that doing so will allow the court to assess the viability of individual cases....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.